Suppr超能文献

治疗股腘动脉疾病:成熟技术与新兴技术

Treating femoropopliteal disease: established and emerging technologies.

作者信息

Diamantopoulos Athanasios, Katsanos Konstantinos

机构信息

Department of Interventional Radiology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.

出版信息

Semin Intervent Radiol. 2014 Dec;31(4):345-52. doi: 10.1055/s-0034-1393971.

Abstract

The femoropopliteal artery is the most common site of disease in patients with peripheral arterial disease and presents some of the greatest challenges for interventional radiology. Many patients can be managed with medical treatment combined with supervised exercise alone. However, a significant proportion, especially those suffering from severe intermittent claudication or critical limb ischemia, will require some form of endovascular or surgical revascularization procedure. During the past few years an endovascular-first approach has gained support from all vascular specialties. Today, even complex lesions can be treated successfully with an endovascular approach. Unfortunately, the unique bio-mechanical properties of this vascular segment have limited long-term patency rates and clinical value of the endovascular options. In this review, the authors discuss the methods and techniques for treatment of femoropopliteal lesions and review the current evidence for commercially available devices on patency outcomes following successful recanalization.

摘要

股腘动脉是外周动脉疾病患者最常见的病变部位,也是介入放射学面临的一些最大挑战所在。许多患者仅通过药物治疗和有监督的运动即可得到处理。然而,相当一部分患者,尤其是那些患有严重间歇性跛行或严重肢体缺血的患者,将需要某种形式的血管内或外科血管重建手术。在过去几年中,血管内优先的治疗方法已得到所有血管专科的支持。如今,即使是复杂病变也可通过血管内方法成功治疗。不幸的是,该血管段独特的生物力学特性限制了血管内治疗选择的长期通畅率和临床价值。在本综述中,作者讨论了股腘病变的治疗方法和技术,并回顾了关于成功再通后商用器械通畅结局的现有证据。

相似文献

1
Treating femoropopliteal disease: established and emerging technologies.
Semin Intervent Radiol. 2014 Dec;31(4):345-52. doi: 10.1055/s-0034-1393971.
4
Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.
Curr Cardiol Rep. 2017 Feb;19(2):10. doi: 10.1007/s11886-017-0823-4.
5
12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
JACC Cardiovasc Interv. 2018 May 28;11(10):934-941. doi: 10.1016/j.jcin.2018.01.276. Epub 2018 May 2.
6
Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
Cardiovasc Revasc Med. 2019 Mar;20(3):210-214. doi: 10.1016/j.carrev.2018.06.018. Epub 2018 Jun 25.
7
9
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.
Circulation. 2016 Apr 12;133(15):1472-83; discussion 1483. doi: 10.1161/CIRCULATIONAHA.115.016900. Epub 2016 Mar 11.
10
Newly approved devices for endovascular treatment of femoropopliteal disease: a review of clinical evidence.
Expert Rev Cardiovasc Ther. 2019 Oct;17(10):729-740. doi: 10.1080/14779072.2019.1675512. Epub 2019 Oct 28.

引用本文的文献

1
Algorithm for the Revascularization of Infrainguinal Arterial Disease.
Vasc Specialist Int. 2025 Mar 18;41:6. doi: 10.5758/vsi.240113.
2
Femoro-popliteal endovascular interventions.
Wideochir Inne Tech Maloinwazyjne. 2024 Jun;19(2):187-197. doi: 10.5114/wiitm.2024.139548. Epub 2024 May 10.
3
Complex Peripheral Arterial Disease in a Case of Multilevel Lesions Treated With Sequential Angioplasty.
Cureus. 2024 May 24;16(5):e60982. doi: 10.7759/cureus.60982. eCollection 2024 May.
4
Directional atherectomy combined with drug-coated balloon angioplasty for superficial femoral arteriosclerosis obliterans.
Ann R Coll Surg Engl. 2023 Sep;105(7):627-631. doi: 10.1308/rcsann.2022.0164. Epub 2023 Mar 16.
6
FAK Activation Promotes SMC Dedifferentiation via Increased DNA Methylation in Contractile Genes.
Circ Res. 2021 Dec 3;129(12):e215-e233. doi: 10.1161/CIRCRESAHA.121.319066. Epub 2021 Oct 27.
7
Endovascular treatment of femoro-popliteal lesions.
Clin Cardiol. 2019 Jan;42(1):175-183. doi: 10.1002/clc.23098. Epub 2018 Dec 4.
8
Swirling Flow and Wall Shear: Evaluating the BioMimics 3D Helical Centerline Stent for the Femoropopliteal Segment.
Int J Vasc Med. 2018 Feb 26;2018:9795174. doi: 10.1155/2018/9795174. eCollection 2018.

本文引用的文献

1
Paclitaxel-coated balloons and aneurysm formation in peripheral vessels.
J Vasc Surg. 2015 Nov;62(5):1320-2. doi: 10.1016/j.jvs.2014.03.291. Epub 2014 May 5.
2
Standards of practice for superficial femoral and popliteal artery angioplasty and stenting.
Cardiovasc Intervent Radiol. 2014 Jun;37(3):592-603. doi: 10.1007/s00270-014-0876-3. Epub 2014 Apr 11.
3
Emerging stent and balloon technologies in the femoropopliteal arteries.
ScientificWorldJournal. 2014 Feb 4;2014:695402. doi: 10.1155/2014/695402. eCollection 2014.
6
Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudication.
J Vasc Interv Radiol. 2013 Oct;24(10):1427-35; quiz 1436. doi: 10.1016/j.jvir.2013.05.057. Epub 2013 Jul 29.
9
Role of bioresorbable stents in the superficial femoral artery.
J Cardiovasc Surg (Torino). 2013 Apr;54(2):225-34.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验